News Releases
Please download and read our company press releases below.
Cambria Biosciences' Chemical Genetics Platform is Featured in Nature Article Describing a New Pharmaceutical Mode of Action
Cambria Biosciences Receives $5.0 Million in Grants and Awards for Neurodegenerative Disease Drug Discovery and Preclinical Development Programs
Link to ALSA Press Release
Cambria Biosciences Announces Collaboration with Pfizer Animal Health in Antiparasitic Drug Discovery
Cambria Biosciences Unveils Novel Epilepsy Drug Discovery Program at the Neurotechnology Industry Organization Conference
Cambria Biosciences Receives TREAT ALSA Grant: Boston-Area Biotechnology Company Partners with Northwestern University in Seeking New Safe and Effective Compounds for the Treatment of Amyotrophic Lateral Sclerosis
Archives